Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical Shares Outstanding 2010-2024 | TAK

Takeda Pharmaceutical shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Takeda Pharmaceutical shares outstanding for the quarter ending December 31, 2024 were 0M, a 100% decline year-over-year.
  • Takeda Pharmaceutical 2025 shares outstanding were 3.158B, a 0.09% decline from 2024.
  • Takeda Pharmaceutical 2024 shares outstanding were 3.161B, a 0.67% increase from 2023.
  • Takeda Pharmaceutical 2023 shares outstanding were 3.14B, a 0.46% decline from 2022.
  
Takeda Pharmaceutical Annual Shares Outstanding
(Millions of Shares)
2025 3,158
2024 3,161
2023 3,140
2022 3,154
2021 3,147
2020 3,132
2019 1,934
2018 1,573
2017 1,572
2016 1,576
2015 1,573
2014 1,581
2013 1,579
2012 1,579
2011 1,579
2010 1,579
2009 1,617
Takeda Pharmaceutical Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31
2024-06-30 3,138
2024-03-31 3,161
2023-12-31 3,170
2023-09-30 3,131
2023-06-30 3,109
2023-03-31 3,140
2022-12-31 3,141
2022-09-30 3,127
2022-06-30 3,091
2022-03-31 3,154
2021-12-31 3,150
2021-09-30 3,161
2021-06-30 3,130
2021-03-31 3,147
2020-12-31 3,151
2020-09-30 3,146
2020-06-30 3,118
2020-03-31 3,132
2019-12-31 3,115
2019-09-30 3,124
2019-06-30 3,111
2018-12-31 1,573
2018-06-30 1,564
2017-06-30 1,560
2016-06-30 1,564
2015-06-30 1,570
2015-03-31 1,574
2014-12-31 1,578
2014-09-30 1,572
2014-06-30 1,575
2014-03-31 1,578
2013-12-31 1,581
2013-09-30 1,578
2013-06-30 1,581
2013-03-31 1,580
2012-12-31 1,579
2012-09-30 1,579
2012-06-30 1,579
2012-03-31 1,579
2011-12-31 1,578
2011-09-30 1,582
2011-03-31 1,579
2010-03-31 1,579
2009-09-30 6
2009-03-31 1,588
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $47.983B $30.087B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.929B 32.24
Zoetis (ZTS) United States $70.240B 26.21
Daiichi Sankyo, - (DSNKY) Japan $44.148B 22.63
BeOne Medicines - (ONC) Cayman Islands $29.241B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.170B 0.00
Merck (MKKGY) Germany $16.905B 12.39
Summit Therapeutics (SMMT) United States $15.537B 0.00
Shionogi (SGIOY) Japan $14.870B 14.90
United Therapeutics (UTHR) United States $13.078B 11.57
Neurocrine Biosciences (NBIX) United States $12.685B 43.45
Orion OYJ (ORINY) Finland $10.469B 28.31
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $8.141B 66.18
Stevanato Group S.p.A (STVN) Italy $7.447B 45.54
Madrigal Pharmaceuticals (MDGL) United States $6.327B 0.00
Ionis Pharmaceuticals (IONS) United States $6.309B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.872B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.242B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.897B 0.00
Hypermarcas (HYPMY) Brazil $2.850B 18.75
Catalyst Pharmaceuticals (CPRX) United States $2.692B 9.43
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
BioCryst Pharmaceuticals (BCRX) United States $2.078B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.066B 0.00
Indivior (INDV) United States $1.919B 8.14
Centessa Pharmaceuticals (CNTA) United Kingdom $1.896B 0.00
ARS Pharmaceuticals (SPRY) United States $1.648B 0.00
Endo (NDOI) United States $1.595B 0.00
Evotec AG (EVO) Germany $1.449B 0.00
Ocular Therapeutix (OCUL) United States $1.448B 0.00
Guardian Pharmacy Services (GRDN) United States $1.304B 0.00
Dyne Therapeutics (DYN) United States $1.208B 0.00
Harrow (HROW) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.088B 21.76
Enliven Therapeutics (ELVN) United States $1.038B 0.00
Verve Therapeutics (VERV) United States $0.996B 0.00
Collegium Pharmaceutical (COLL) United States $0.967B 5.22
Akebia Therapeutics (AKBA) United States $0.964B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.929B 0.00
Ardelyx (ARDX) United States $0.880B 0.00
Elite Pharmaceuticals (ELTP) United States $0.828B 0.00
Cronos Group (CRON) Canada $0.729B 0.00
Xeris Biopharma Holdings (XERS) United States $0.729B 0.00
Liminatus Pharma (LIMN) United States $0.694B 0.00
Xencor (XNCR) United States $0.589B 0.00
Altimmune (ALT) United States $0.583B 0.00
KalVista Pharmaceuticals (KALV) United States $0.582B 0.00
USANA Health Sciences (USNA) United States $0.572B 12.43
Amylyx Pharmaceuticals (AMLX) United States $0.571B 0.00
Relay Therapeutics (RLAY) United States $0.567B 0.00
Regulus Therapeutics (RGLS) United States $0.565B 0.00
Bioventus (BVS) United States $0.555B 14.08
Theravance Biopharma (TBPH) United States $0.534B 0.00
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
AleAnna (ANNA) United States $0.484B 0.00
Siga Technologies (SIGA) United States $0.457B 9.55
Oruka Therapeutics (ORKA) United States $0.440B 0.00
Organogenesis (ORGO) United States $0.439B 0.00
Tourmaline Bio (TRML) United States $0.435B 0.00
Savara (SVRA) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 9.03
Heron Therapeutics (HRTX) United States $0.328B 0.00
Aquestive Therapeutics (AQST) United States $0.319B 0.00
Nektar Therapeutics (NKTR) United States $0.304B 0.00
Nature's Sunshine Products (NATR) United States $0.279B 25.59
Tonix Pharmaceuticals Holding (TNXP) United States $0.262B 0.00
Esperion Therapeutics (ESPR) United States $0.212B 0.00
MediWound (MDWD) Israel $0.211B 0.00
OmniAb (OABI) United States $0.209B 0.00
Nanobiotix S.A (NBTX) France $0.208B 0.00
Aldeyra Therapeutics (ALDX) United States $0.201B 0.00
Larimar Therapeutics (LRMR) United States $0.191B 0.00
ProKidney (PROK) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.186B 0.00
4D Molecular Therapeutics (FDMT) United States $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Galectin Therapeutics (GALT) United States $0.153B 0.00
Lyell Immunopharma (LYEL) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Avita Medical (RCEL) United States $0.131B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.117B 0.00
Cardiol Therapeutics (CRDL) Canada $0.111B 0.00
Champions Oncology (CSBR) United States $0.108B 17.68
Corbus Pharmaceuticals Holdings (CRBP) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
Fractyl Health (GUTS) United States $0.083B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Inotiv (NOTV) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
PMV Pharmaceuticals (PMVP) United States $0.060B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 36.67
Klotho Neurosciences (KLTO) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
FibroGen (FGEN) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Scienture Holdings (SCNX) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
GlycoMimetics (CBIO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00